Children´s Hospital and Research Center, Oakland Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2019
NCT03811028
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Children´s Hospital and Research Center, Oakland

Active Ingredients

Drugs in Phase 2 Trials (1)

sobi-003 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mucopolysaccharidosis III (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1